vs
AXCELIS TECHNOLOGIES INC（ACLS）与OPKO HEALTH, INC.（OPK）财务数据对比。点击上方公司名可切换其他公司
AXCELIS TECHNOLOGIES INC的季度营收约是OPKO HEALTH, INC.的1.6倍（$238.3M vs $148.5M），AXCELIS TECHNOLOGIES INC净利率更高（14.4% vs -21.1%，领先35.4%），AXCELIS TECHNOLOGIES INC同比增速更快（-5.6% vs -19.2%），AXCELIS TECHNOLOGIES INC自由现金流更多（$-8.9M vs $-28.6M），过去两年AXCELIS TECHNOLOGIES INC的营收复合增速更高（-2.8% vs -7.5%）
Axcelis Technologies是一家美国半导体设备供应商，1995年成立，总部位于美国马萨诸塞州贝弗利。公司面向全球半导体制造行业，从事半导体生产核心设备的设计、制造及服务，主营产品包括高中电流、高能离子注入系统以及半导体芯片制造用固化系统。
OPKO Health是一家聚焦诊断与医药领域的医疗企业，核心业务涵盖医疗检测与药品研发生产，在纳斯达克和特拉维夫证券交易所挂牌上市，股票代码为OPK。
ACLS vs OPK — 直观对比
营收规模更大
ACLS
是对方的1.6倍
$148.5M
营收增速更快
ACLS
高出13.6%
-19.2%
净利率更高
ACLS
高出35.4%
-21.1%
自由现金流更多
ACLS
多$19.7M
$-28.6M
两年增速更快
ACLS
近两年复合增速
-7.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $238.3M | $148.5M |
| 净利润 | $34.3M | $-31.3M |
| 毛利率 | 47.0% | 43.1% |
| 营业利润率 | 15.2% | -25.8% |
| 净利率 | 14.4% | -21.1% |
| 营收同比 | -5.6% | -19.2% |
| 净利润同比 | -31.3% | -322.8% |
| 每股收益（稀释后） | $1.11 | $-0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACLSOPK
| Q4 25 | $238.3M | $148.5M | ||
| Q3 25 | $213.6M | $151.7M | ||
| Q2 25 | $194.5M | $156.8M | ||
| Q1 25 | $192.6M | $150.0M | ||
| Q4 24 | $252.4M | $183.6M | ||
| Q3 24 | $256.6M | $173.6M | ||
| Q2 24 | $256.5M | $182.2M | ||
| Q1 24 | $252.4M | $173.7M |
净利润ACLSOPK
| Q4 25 | $34.3M | $-31.3M | ||
| Q3 25 | $26.0M | $21.6M | ||
| Q2 25 | $31.4M | $-148.4M | ||
| Q1 25 | $28.6M | $-67.6M | ||
| Q4 24 | $50.0M | $14.0M | ||
| Q3 24 | $48.6M | $24.9M | ||
| Q2 24 | $50.9M | $-10.3M | ||
| Q1 24 | $51.6M | $-81.8M |
毛利率ACLSOPK
| Q4 25 | 47.0% | 43.1% | ||
| Q3 25 | 41.6% | 32.9% | ||
| Q2 25 | 44.9% | 31.5% | ||
| Q1 25 | 46.1% | 28.4% | ||
| Q4 24 | 46.0% | 46.1% | ||
| Q3 24 | 42.9% | 23.1% | ||
| Q2 24 | 43.8% | 28.4% | ||
| Q1 24 | 46.0% | 24.2% |
营业利润率ACLSOPK
| Q4 25 | 15.2% | -25.8% | ||
| Q3 25 | 11.7% | 31.7% | ||
| Q2 25 | 14.9% | -38.3% | ||
| Q1 25 | 15.1% | -44.8% | ||
| Q4 24 | 21.6% | -18.0% | ||
| Q3 24 | 18.3% | 8.2% | ||
| Q2 24 | 20.6% | -33.9% | ||
| Q1 24 | 22.4% | -41.2% |
净利率ACLSOPK
| Q4 25 | 14.4% | -21.1% | ||
| Q3 25 | 12.2% | 14.3% | ||
| Q2 25 | 16.1% | -94.7% | ||
| Q1 25 | 14.8% | -45.1% | ||
| Q4 24 | 19.8% | 7.6% | ||
| Q3 24 | 18.9% | 14.3% | ||
| Q2 24 | 19.8% | -5.7% | ||
| Q1 24 | 20.4% | -47.1% |
每股收益（稀释后）ACLSOPK
| Q4 25 | $1.11 | $-0.04 | ||
| Q3 25 | $0.83 | $0.03 | ||
| Q2 25 | $0.98 | $-0.19 | ||
| Q1 25 | $0.88 | $-0.10 | ||
| Q4 24 | $1.54 | $0.02 | ||
| Q3 24 | $1.49 | $0.03 | ||
| Q2 24 | $1.55 | $-0.01 | ||
| Q1 24 | $1.57 | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $374.3M | $364.4M |
| 总债务越低越好 | — | $344.0M |
| 股东权益账面价值 | $1.0B | $1.3B |
| 总资产 | $1.4B | $1.9B |
| 负债/权益比越低杠杆越低 | — | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资ACLSOPK
| Q4 25 | $374.3M | $364.4M | ||
| Q3 25 | $449.6M | $412.0M | ||
| Q2 25 | $549.8M | $267.3M | ||
| Q1 25 | $587.1M | $428.8M | ||
| Q4 24 | $571.3M | $426.6M | ||
| Q3 24 | $579.4M | $400.1M | ||
| Q2 24 | $548.3M | $40.6M | ||
| Q1 24 | $530.2M | $75.6M |
总债务ACLSOPK
| Q4 25 | — | $344.0M | ||
| Q3 25 | — | $344.2M | ||
| Q2 25 | — | $343.3M | ||
| Q1 25 | — | $439.2M | ||
| Q4 24 | — | $437.2M | ||
| Q3 24 | — | $441.0M | ||
| Q2 24 | — | $201.9M | ||
| Q1 24 | — | $350.1M |
股东权益ACLSOPK
| Q4 25 | $1.0B | $1.3B | ||
| Q3 25 | $1.0B | $1.3B | ||
| Q2 25 | $1.0B | $1.3B | ||
| Q1 25 | $1.0B | $1.3B | ||
| Q4 24 | $1.0B | $1.4B | ||
| Q3 24 | $975.6M | $1.4B | ||
| Q2 24 | $934.9M | $1.4B | ||
| Q1 24 | $901.7M | $1.3B |
总资产ACLSOPK
| Q4 25 | $1.4B | $1.9B | ||
| Q3 25 | $1.4B | $2.0B | ||
| Q2 25 | $1.3B | $2.0B | ||
| Q1 25 | $1.3B | $2.1B | ||
| Q4 24 | $1.3B | $2.2B | ||
| Q3 24 | $1.3B | $2.3B | ||
| Q2 24 | $1.3B | $2.0B | ||
| Q1 24 | $1.3B | $2.0B |
负债/权益比ACLSOPK
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.33× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.31× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.28× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.6M | $-25.9M |
| 自由现金流经营现金流 - 资本支出 | $-8.9M | $-28.6M |
| 自由现金流率自由现金流/营收 | -3.7% | -19.3% |
| 资本支出强度资本支出/营收 | 1.0% | 1.8% |
| 现金转化率经营现金流/净利润 | -0.19× | — |
| 过去12个月自由现金流最近4个季度 | $107.0M | $-190.8M |
8季度趋势，按日历期对齐
经营现金流ACLSOPK
| Q4 25 | $-6.6M | $-25.9M | ||
| Q3 25 | $45.4M | $-34.6M | ||
| Q2 25 | $39.7M | $-83.4M | ||
| Q1 25 | $39.8M | $-34.6M | ||
| Q4 24 | $12.8M | $-44.4M | ||
| Q3 24 | $45.7M | $-77.1M | ||
| Q2 24 | $40.1M | $-26.4M | ||
| Q1 24 | $42.2M | $-35.6M |
自由现金流ACLSOPK
| Q4 25 | $-8.9M | $-28.6M | ||
| Q3 25 | $43.3M | $-37.8M | ||
| Q2 25 | $37.7M | $-86.7M | ||
| Q1 25 | $34.8M | $-37.7M | ||
| Q4 24 | $8.1M | $-49.8M | ||
| Q3 24 | $41.8M | $-85.0M | ||
| Q2 24 | $38.1M | $-33.7M | ||
| Q1 24 | $40.6M | $-40.0M |
自由现金流率ACLSOPK
| Q4 25 | -3.7% | -19.3% | ||
| Q3 25 | 20.3% | -24.9% | ||
| Q2 25 | 19.4% | -55.3% | ||
| Q1 25 | 18.1% | -25.2% | ||
| Q4 24 | 3.2% | -27.1% | ||
| Q3 24 | 16.3% | -49.0% | ||
| Q2 24 | 14.8% | -18.5% | ||
| Q1 24 | 16.1% | -23.0% |
资本支出强度ACLSOPK
| Q4 25 | 1.0% | 1.8% | ||
| Q3 25 | 0.9% | 2.1% | ||
| Q2 25 | 1.0% | 2.1% | ||
| Q1 25 | 2.6% | 2.1% | ||
| Q4 24 | 1.8% | 2.9% | ||
| Q3 24 | 1.5% | 4.6% | ||
| Q2 24 | 0.8% | 4.0% | ||
| Q1 24 | 0.6% | 2.6% |
现金转化率ACLSOPK
| Q4 25 | -0.19× | — | ||
| Q3 25 | 1.75× | -1.60× | ||
| Q2 25 | 1.27× | — | ||
| Q1 25 | 1.39× | — | ||
| Q4 24 | 0.26× | -3.17× | ||
| Q3 24 | 0.94× | -3.10× | ||
| Q2 24 | 0.79× | — | ||
| Q1 24 | 0.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACLS
| Products | $224.6M | 94% |
| Services | $13.7M | 6% |
OPK
| Services | $71.1M | 48% |
| Transfer Of Intellectual Property And Other | $33.7M | 23% |
| IE | $22.1M | 15% |
| Rayaldee | $8.8M | 6% |
| Barda Agreement | $6.8M | 5% |
| MX | $6.3M | 4% |
